MetLife Investment Management’s Avadel Pharmaceuticals AVDL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$495K Hold
55,961
﹤0.01% 1679
2025
Q1
$438K Sell
55,961
-1,107
-2% -$8.67K ﹤0.01% 1790
2024
Q4
$600K Buy
57,068
+3,271
+6% +$34.4K ﹤0.01% 1704
2024
Q3
$706K Buy
53,797
+30,313
+129% +$398K ﹤0.01% 1593
2024
Q2
$330K Buy
+23,484
New +$330K ﹤0.01% 1951